Affinity Asset Advisors, LLC Enochian Biosciences Inc Transaction History
Affinity Asset Advisors, LLC
- $560 Million
- Q4 2024
A detailed history of Affinity Asset Advisors, LLC transactions in Enochian Biosciences Inc stock. As of the latest transaction made, Affinity Asset Advisors, LLC holds 200,000 shares of ENOB stock, worth $919,999. This represents 0.16% of its overall portfolio holdings.
Number of Shares
200,000Holding current value
$919,999% of portfolio
0.16%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ENOB
# of Institutions
58Shares Held
19MCall Options Held
41.4KPut Options Held
49.2K-
Vanguard Group Inc Valley Forge, PA5.72MShares$26.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.66MShares$16.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.33MShares$10.7 Million0.0% of portfolio
-
State Street Corp Boston, MA2.06MShares$9.5 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL889KShares$4.09 Million0.0% of portfolio
About Enochian Biosciences Inc
- Ticker ENOB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,950,000
- Market Cap $244M
- Description
- Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...